Mesenchymal Chondrosarcoma

This is another type of bone cancer called chondrosarcoma. It's a less common and often more aggressive form. It has a unique look under a microscope, showing both small, dense cancer cells and areas of cartilage. It tends to happen in younger people and is more likely to spread to other parts of the body.

Condition

What people with Mesenchymal Chondrosarcoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Mesenchymal Chondrosarcoma?

NameHow it went

About Mesenchymal Chondrosarcoma

What It Is

Mesenchymal chondrosarcoma is a rare, fast-growing cancer that belongs to the chondrosarcoma family, a group of sarcomas whose cells make cartilage. Under the microscope it has two parts: small, tightly packed round cells mixed with islands of cartilage. That small-cell component is what makes it behave very differently from the common, slow-growing form of chondrosarcoma. It is classed as high grade, meaning it tends to grow quickly and has a strong tendency to spread, most often to the lungs and other bones. It makes up only a few percent of chondrosarcomas and most often appears in people in their 20s and 30s, though children and older adults can be affected. In bone, it favors the jaw and other bones of the face and skull, the ribs, the pelvis and the spine. About a third of cases start outside bone, in soft tissue, and a common site is the meninges, the membranes covering the brain and spinal cord.

Causes & Risk Factors

The cause of mesenchymal chondrosarcoma is not known, and no lifestyle, environmental or family risk factor has been established. In nearly all cases, the tumor cells carry a specific genetic change in which two genes, HEY1 and NCOA2, are fused together. This fusion appears to drive the cancer's growth, but it arises within the tumor itself, and researchers do not know what triggers it.

How It's Diagnosed

Symptoms depend on where the tumor grows. In bone, the usual signs are pain that does not ease with rest, swelling or a lump. A tumor in the jaw can cause facial swelling, pain or loose teeth. A tumor inside the skull most often causes headaches as it presses on the brain. Imaging with magnetic resonance imaging (MRI) and computed tomography (CT) scans shows the tumor's size and position, and scans of the chest and body check whether it has spread. A biopsy, taking a sample of the tumor, is essential. Because mesenchymal chondrosarcoma can look like other small round cell cancers such as Ewing sarcoma, or like benign tumors, the sample should be reviewed by a pathologist experienced in sarcoma. Testing the tissue for the HEY1::NCOA2 gene fusion helps confirm the diagnosis. Getting the subtype right matters because treatment differs from that of ordinary chondrosarcoma.

Treatment Options

Treatment is best planned at a specialized sarcoma center, where surgeons, cancer doctors and radiation specialists decide together. Because the disease is so rare, recommendations rest on a limited number of retrospective studies rather than clinical trials. For a tumor that has not spread, surgery to remove it completely, with a margin of healthy tissue around it, is the most important step. Leaving tumor cells at the edge is strongly linked to the cancer returning. When a tumor sits in the jaw, skull, spine or pelvis, complete removal can be difficult and may involve reconstruction. Unlike ordinary chondrosarcoma, this subtype can respond to chemotherapy. Many centers give combination chemotherapy before and after surgery, often using regimens developed for Ewing sarcoma that combine doxorubicin, an anthracycline, with alkylating drugs such as ifosfamide or cyclophosphamide. Studies suggest it may lower the chance of relapse, but whether it helps people live longer is still uncertain. These regimens are demanding and can affect blood counts, the heart, the kidneys and the nerves, so the decision weighs likely benefit against that burden. Radiation therapy is used when the tumor cannot be fully removed, when surgery leaves cancer cells at the margin, or to control tumors that have spread. For cancer that has spread or returned, chemotherapy can shrink tumors in some people and slow the disease, though it is not expected to cure it. Trabectedin, a chemotherapy drug used for some sarcomas, has given lasting disease control in a small number of people after other treatments. Surgery or targeted radiation to a few spots of spread, such as in the lungs, is sometimes an option, and clinical trials are worth asking about.

What to Expect

Outlook varies widely. The most important factor is whether the cancer has spread when it is found, which is the case for roughly 15 to 25 percent of people. Across published studies, about 50 to 70 percent of people are alive five years after diagnosis, with better results when the tumor is localized and completely removed and much shorter survival when it has already spread. Larger tumors are more likely to spread. Because these figures come from small groups of patients treated over many years, they cannot predict any one person's course. Recovery depends heavily on the tumor's location. Surgery on the jaw or face can affect eating, speech and appearance, while surgery on a limb or the pelvis may require rehabilitation. This cancer can come back many years after treatment, often in the lungs or other bones, so regular check-ups with imaging continue for a long time, well beyond the first five years.

When to Seek Help

See a doctor about bone pain that persists or worsens, especially pain that does not ease with rest, or about a lump or swelling that is growing. After treatment, report new pain, a new lump or other new symptoms rather than waiting for the next scheduled scan. During chemotherapy, call your care team right away for a fever of 100.5°F (38°C) or higher, chills or other signs of infection, because infection while blood counts are low can become serious quickly.

Questions to Ask Your Doctor

  1. 1.Has the diagnosis been confirmed by a sarcoma pathologist, including testing for the HEY1::NCOA2 gene fusion?
  2. 2.Can the tumor be removed completely, and what would surgery mean for how I eat, speak, move or look afterward?
  3. 3.What do you expect chemotherapy or radiation to add in my situation, and what side effects would I face?
  4. 4.Is there a clinical trial or a sarcoma specialist center I should consider?
  5. 5.How often will I need scans after treatment, and for how many years?

Last reviewed • Oct 2026

Educational content, not medical advice.